Literature DB >> 33650774

Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers.

Christoph H Mayr1, Lukas M Simon2, Gabriela Leuschner1,3, Meshal Ansari1,2, Janine Schniering1,4, Philipp E Geyer5, Ilias Angelidis1, Maximilian Strunz1, Pawandeep Singh1, Nikolaus Kneidinger3, Frank Reichenberger6, Edith Silbernagel6, Stephan Böhm7, Heiko Adler8, Michael Lindner6,9, Britta Maurer4, Anne Hilgendorff10, Antje Prasse11, Jürgen Behr3,6, Matthias Mann5, Oliver Eickelberg12, Fabian J Theis2, Herbert B Schiller1.   

Abstract

The correspondence of cell state changes in diseased organs to peripheral protein signatures is currently unknown. Here, we generated and integrated single-cell transcriptomic and proteomic data from multiple large pulmonary fibrosis patient cohorts. Integration of 233,638 single-cell transcriptomes (n = 61) across three independent cohorts enabled us to derive shifts in cell type proportions and a robust core set of genes altered in lung fibrosis for 45 cell types. Mass spectrometry analysis of lung lavage fluid (n = 124) and plasma (n = 141) proteomes identified distinct protein signatures correlated with diagnosis, lung function, and injury status. A novel SSTR2+ pericyte state correlated with disease severity and was reflected in lavage fluid by increased levels of the complement regulatory factor CFHR1. We further discovered CRTAC1 as a biomarker of alveolar type-2 epithelial cell health status in lavage fluid and plasma. Using cross-modal analysis and machine learning, we identified the cellular source of biomarkers and demonstrated that information transfer between modalities correctly predicts disease status, suggesting feasibility of clinical cell state monitoring through longitudinal sampling of body fluid proteomes.
© 2021 The Authors. Published under the terms of the CC BY 4.0 license.

Entities:  

Keywords:  biomarker; data integration; fibrosis; proteomics; single-cell RNA-seq

Year:  2021        PMID: 33650774     DOI: 10.15252/emmm.202012871

Source DB:  PubMed          Journal:  EMBO Mol Med        ISSN: 1757-4676            Impact factor:   12.137


  11 in total

1.  Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study.

Authors:  Seul Kee Byeon; Anil K Madugundu; Kishore Garapati; Madan Gopal Ramarajan; Mayank Saraswat; Praveen Kumar-M; Travis Hughes; Rameen Shah; Mrinal M Patnaik; Nicholas Chia; Susan Ashrafzadeh-Kian; Joseph D Yao; Bobbi S Pritt; Roberto Cattaneo; Mohamed E Salama; Roman M Zenka; Benjamin R Kipp; Stefan K G Grebe; Ravinder J Singh; Amir A Sadighi Akha; Alicia Algeciras-Schimnich; Surendra Dasari; Janet E Olson; Jesse R Walsh; A J Venkatakrishnan; Garrett Jenkinson; John C O'Horo; Andrew D Badley; Akhilesh Pandey
Journal:  Lancet Digit Health       Date:  2022-07-11

2.  ScRNA-seq expression of IFI27 and APOC2 identifies four alveolar macrophage superclusters in healthy BALF.

Authors:  Xin Li; Fred W Kolling; Daniel Aridgides; Diane Mellinger; Alix Ashare; Claudia V Jakubzick
Journal:  Life Sci Alliance       Date:  2022-07-12

3.  Mapping the cardiac vascular niche in heart failure.

Authors:  Fabian Peisker; Maurice Halder; James Nagai; Susanne Ziegler; Nadine Kaesler; Konrad Hoeft; Ronghui Li; Eric M J Bindels; Christoph Kuppe; Julia Moellmann; Michael Lehrke; Christian Stoppe; Michael T Schaub; Rebekka K Schneider; Ivan Costa; Rafael Kramann
Journal:  Nat Commun       Date:  2022-05-31       Impact factor: 17.694

4.  Consensus Gene Co-Expression Network Analysis Identifies Novel Genes Associated with Severity of Fibrotic Lung Disease.

Authors:  Sudhir Ghandikota; Mihika Sharma; Harshavardhana H Ediga; Satish K Madala; Anil G Jegga
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

5.  Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis.

Authors:  Laurens J De Sadeleer; John E McDonough; Jonas C Schupp; Xiting Yan; Arno Vanstapel; Anke Van Herck; Stephanie Everaerts; Vincent Geudens; Annelore Sacreas; Tinne Goos; Celine Aelbrecht; Tim S Nawrot; Dries S Martens; Dominique Schols; Sandra Claes; Johny A Verschakelen; Eric K Verbeken; Maximilian Ackermann; Anabelle Decottignies; Manon Mahieu; Tillie-Louise Hackett; James C Hogg; Bart M Vanaudenaerde; Stijn E Verleden; Naftali Kaminski; Wim A Wuyts
Journal:  Am J Respir Crit Care Med       Date:  2022-01-01       Impact factor: 21.405

6.  BAL Transcriptomes Characterize Idiopathic Pulmonary Fibrosis Endotypes With Prognostic Impact.

Authors:  Laurens J De Sadeleer; Stijn E Verleden; Jonas C Schupp; John E McDonough; Tinne Goos; Jonas Yserbyt; Elena Bargagli; Paola Rottoli; Naftali Kaminski; Antje Prasse; Wim A Wuyts
Journal:  Chest       Date:  2022-01-19       Impact factor: 10.262

7.  Fibromine is a multi-omics database and mining tool for target discovery in pulmonary fibrosis.

Authors:  Dionysios Fanidis; Panagiotis Moulos; Vassilis Aidinis
Journal:  Sci Rep       Date:  2021-11-05       Impact factor: 4.379

Review 8.  Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis.

Authors:  Olivier Burgy; Sabrina Loriod; Guillaume Beltramo; Philippe Bonniaud
Journal:  Cells       Date:  2022-04-03       Impact factor: 6.600

9.  Longitudinal Serum Proteome Characterization of COVID-19 Patients With Different Severities Revealed Potential Therapeutic Strategies.

Authors:  Songfeng Wu; Yuan Xu; Jian Zhang; Xiaoju Ran; Xue Jia; Jing Wang; Longqin Sun; Huan Yang; Yulei Li; Bin Fu; Changwu Huang; Pu Liao; Wei Sun
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

Review 10.  Emerging Roles of Airway Epithelial Cells in Idiopathic Pulmonary Fibrosis.

Authors:  Ashesh Chakraborty; Michal Mastalerz; Meshal Ansari; Herbert B Schiller; Claudia A Staab-Weijnitz
Journal:  Cells       Date:  2022-03-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.